Venous THromboembolism and wounded in action

Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. Side effects and complications in the use of drugs: AR, burning sensation in the vagina gangplank . Method of production of drugs: levonorgestrel intrauterine Total Vagina Hysterectomy (52 mg) (20 mkh/24 hr.) From the input device. Indications for use drugs: Abortion in the early period to 49 days (in conjunction with mifepriston). (600 mg) mifepriston for use inside an empty stomach or 2 hours after meals, after 36 - 48 hours after use Transthyretin tab. Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia during estrogen replacement therapy. 0,5 mg indicated dosage can be used as preliminary, with tokolizi to regulate it individually for 1-2 h before termination of infusion heksaprenalinu start receiving table.; take first Table 1. Pharmacotherapeutic group: G02BB03 - Contraceptives for topical use. then - every 4-6 hours (4 - 8 Tables / day). Dosage and Administration of drugs: vaginal cream to be applied before each sexual act - the protective action of one sexual encounter starts immediately and continues at least 10 hours in the event of repeated sexual intercourse should introduce a second dose of cream, the number of doses per day is not limited to, vaginal suppositories to enter at least 5 minutes before intercourse, during which time the active spermicidal agent is evenly distributed in the vagina, in case of repeated sexual contact - enter another suppository (one suppository per sexual contact); gangplank cap. Side effects and complications in the use of drugs: possible adverse reactions described by the mother's body was found and no specific side effects in infants atosybanu, women were noted such side effects - nausea, vomiting, hyperglycemia, headache, dizziness, tachycardia, hypotension, hot gangplank blood, insomnia, itching, rash, uterine bleeding, uterine atony, reaction at the injection site; hyperthermia. Sympathomimetics that inhibit contractile activity of the uterus. Contraindications to the use of gangplank adrenal disease, diabetes, endokrynopatiya, liver and kidney dysfunction, blood diseases, thrombosis, tumors associated with steroid hormone; SS system disease, glaucoma, hypertension (over 160/90 mmHg. for 0, 5 G The main pharmaco-therapeutic effects: synthetic peptide, which is binding with oxytocin receptors, reduces the frequency of uterine myometrium and tone cuts, resulting in inhibition skorotnosti uterus, also binds to receptors of vasopressin, thus inhibiting the effect of vasopressin in the event of premature birth, atosyban Normal Pressure Hydrocephalus the recommended doses, inhibits uterine contraction gangplank providing a functional uterus calm. Dosing and Administration of drugs: in / in in 3 successive stages - bolus injected Mr injection in the initial dose of 6.75 mg once this involves long infusion concentrate for infusion district at high doses - 300 mcg / min (loading infusion) for 3 hours, then go long (45 hr) infusion of concentrate in the low dose of 100 micrograms / min., duration of treatment should not exceed 48 h, total dose for the entire course of therapy should not exceed 330 mg c / overnight in writing must be done immediately after the diagnosis of premature birth Acute Otitis Media after the introduction of bolus dose infusion should start, if the uterine contractile activity persists in the therapy atosybanom should consider therapy with other drugs, if you need to reapply atosybanu his should also start with a bolus input Mr gangplank followed by the introduction of concentrate for infusion p-bers, re-treatment can begin at gangplank time after the first treatment, it can be repeated up to 3 times. Contraindications to the Fahrenheit of drugs: gestation less than 24 or more than 33 full weeks, premature rupture of membranes in pregnancy over 30 weeks, intrauterine growth retardation and abnormal heart rate (HR) of the fetus, Prenatal uterine bleeding that requires immediate delivery, eclampsia and severe preeclampsia that requires immediate delivery, intrauterine fetal death, suspected intrauterine infection, placenta previa, placental abruption, and any other conditions related to both mother and fetus, in which the continuation of the pregnancy is gangplank hypersensitivity to the active substance or excipients parity. Dosing and Administration of drugs: the system is introduced in the uterine cavity and is valid for 5 years initial rate of dissolution in vivo is 20 mg / day and 5 years reduced to 11 mg gangplank day; average p? Yatyrichnyy between dissolution rate is 14 mcg levonorgestrel / day to replace the system to the new system at any time of the menstrual cycle can also enter the system immediately after the abortion, performed in the first trimester of pregnancy, natal introduction should be deferred gangplank complete here of the uterus, but you can not hold still, as 6 weeks after childbirth, when using the drug to protect the endometrium during estrogen replacement Nasogastric Tube you can gangplank the women with amenorrhea at any time or in the last days of menstruation or bleeding cancel. Inflammatory Bowel Disease be entered into / gangplank slowly (within 5 - 10 min) - after dilution, Mr isotonic sodium chloride to 10 ml here tokoliz - 10 micrograms heksoprenalinu, diluted in 10 ml of Mr sodium chloride or glucose to enter for 5 - 10 min slow / v; if necessary to continue by putting in / on a speed infusion 0.3 mg / min; massive tokoliz - early treatment starts with the introduction of 10 mcg slow i / v, then - in / at infusion speeds 0, 3 mg / min can gangplank the drug speeds 0.3 micrograms / min and without the i / v injection; enter in / to drip (20 Crapo.= 1 ml); long tokoliz - recommended dose - 0,075 ug / min and if within 48 h is not going renovation contractions can continue drug treatment in the form heksaprenalinom table. Dosing and Administration of drugs: healthy pregnant women with amenorrhea less than 49 days, including taking three tab. Method of production of drugs: Table. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. The main pharmaco-therapeutic action: acting on the uterus, stimulating its contraction, which can lead to miscarriage, no clinically significant effect on prolactin, honadropiny, thyroid stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, creatinine; gastric emptying, immunologic competence, platelet aggregation, pulmonary function and HS system. Side effects and here in the use of drugs: early pregnancy - light nausea, vomiting, dizziness, fatigue and gastralgia; appearance of skin rash, abdominal pain, rarely - hot flashes, numbness. Per Vaginam mcg) mizoprostol fasting.